نتایج جستجو برای: prevention of thalassemia

تعداد نتایج: 21183850  

Journal: :international journal of hematology-oncology and stem cell research 0
mohammad ali mashhadi health promotion research center, zahedan university of medical sciences, zahedan, iran. zahra heidari department of internal medicine, ali ebne abitaleb hospital, zahedan university of medical sciences, zahedan, iran. zahra sepehri department of internal medicine, amir al momenin hospital, zabol university of medical sciences, zabol, iran. ali reza bakhshipour department of internal medicine, ali ebne abitaleb hospital, zahedan university of medical sciences, zahedan, iran. azra karimkoshte department of internal medicine, ali ebne abitaleb hospital, zahedan university of medical sciences, zahedan, iran.

introduction: there are limited reports about selenium status in major thalassemia patients. the aim of this study is evaluation of selenium status in patients with major thalassemia south east of iran with large sample size and wide range of age. this study compared selenium status with other sites of the world. methods: in this study 369 cases that had major thalassemia for more than 5 years ...

Journal: :Turkish journal of haematology : official journal of Turkish Society of Haematology 2011
Stamatia Theodoridou Vasilios Perifanis Stella Kotsiopoulou Olga Karakasidou Vasiliki Aletra Michael Alemayehou

The phenotypic and molecular diversity of compound heterozygosity for thalassemic genes in Greece is extensive. The interaction of silent and classic β-thalassemia results in the clinical phenotype of thalassemia intermedia. We report the clinical and hematological findings in an 18-year-old female referred to our hemoglobinopathy prevention unit that was observed to be compound heterozygote fo...

Journal: :iranian journal of blood and cancer 0
azamsadat hashemi mahboobeh abrishamkar ali reza jenabzade ziae eslami

background: hydroxyurea (hu) is a well known chemotherapeutic agent that has been used largely for various myeloproliferative diseases over the past 20 years. in β-thalassemia, the effect of hu is much less clear and remains controversial. this study was undertaken to describe the hematologic and clinical responses of thalassemia major and intermediate patients to hu treatment during 2 years. m...

Journal: :American journal of clinical pathology 2002
Jones Alana K Bergstrome Annette Poon

We prospectively compared a single-tube multiplex polymerase chain reaction (PCR) for detecting alpha-thalassemia with our current approach using 452 blood samples. Initial evaluation of 89 specimens revealed sensitivity and specificity, respectively, for the hemoglobin H inclusion body test (HbH prep) vs PCR for detecting alpha0-thalassemia carriers of 0.79 and 0.96 and for a mean corpuscular ...

Journal: :caspian journal of pediatrics 0
farzan khairkhah babol hassan mahmoodi nesheli babol alireza yahyaei babol elmira khodabakhsh babol seyed reza hosseini babol

background: since the reduction of mental health in patients with thalassemia may affect the quality of life and cause dysfunction in various dimensions, so the assessment of this disorder is necessary to choose the appropriate treatment. therefore, the aim of this study was to investigate the mental health and quality of life in patients with thalassemia major. methods: in this cross-sectional...

2015
Anshuman Paria Baishakhi Paria Soma Sengupta Goutam Das

β Thalassemia Trait(BTT) produces mild ineffective erythropoiesis and associated increased iron absorption from the gut. Based on these reasons it had been suggested that BTT confers an advantage in maintaining iron balance, in which case prevalence of iron deficiency should be lower in those with the trait. This Study was carried out to determine the frequency of coexistence of iron deficiency...

Journal: :Annals of Pathology and Laboratory Medicine 2022

Introduction: Hemoglobinopathies and thalassemias are the most common single gene disorders in world. World Health Organization figures estimate that 5% of world populations carriers a potentially pathological hemoglobin (Hb) gene. The general incidence thalassemia trait sickle cell anaemia India varies between 3-17% 1-44% respectively3 but because consanguinity, caste area endogamy, some commu...

Journal: :iranian journal of blood and cancer 0
keikhaei b hirad far a abolghasemi h mousakhani h ghanavat m moghadam m

background: transfusion is the mainstay treatment of patients with thalassemia major and occasionally in thalassemia intermediate. alloimmunization is an unwanted side effect of blood transfusion. the present study intended to determine the frequency of alloimmunization in patients with β- thalassemia major and thalassemia intermediate in southwest iran. patients and methods: this was a cross-s...

Journal: :Clinical chemistry 1998
S Fucharoen P Winichagoon R Wisedpanichkij B Sae-Ngow R Sriphanich W Oncoung W Muangsapaya J Chowthaworn S Kanokpongsakdi A Bunyaratvej A Piankijagum C Dewaele

The conventional approach to qualitative and quantitative analyses of hemoglobin (Hb) molecules for the diagnoses of hemoglobinopathies requires a combination of tests. We used an automated HPLC (VARIANT) system to study alpha-thalassemia and beta-thalassemia syndromes in Thailand. The beta-thalassemia short program is applicable to the diagnosis of alpha-thalassemia and beta-thalassemia disord...

2012
Şinasi Özsoylu

I enjoyed reading Bilgen et al.’s case report, The effect of HBB: (c*+96T>C (3’UTR+1570 T>C) on the mild β-thalassemia intermedia pheonotype, in the recent issue of the Journal (2011; 28: 219-222). I congratulate the authors for exploring at the molecular level at least one of the thalassemia minima that fits well with the present clinical thalassemia nomenclature. Based on their clinical descr...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید